FEZZA, FILOMENA
 Distribuzione geografica
Continente #
NA - Nord America 19.498
EU - Europa 1.196
AS - Asia 210
Continente sconosciuto - Info sul continente non disponibili 8
SA - Sud America 7
OC - Oceania 5
AF - Africa 2
Totale 20.926
Nazione #
US - Stati Uniti d'America 19.492
UA - Ucraina 256
IE - Irlanda 183
DE - Germania 171
IT - Italia 131
CN - Cina 125
SE - Svezia 98
FR - Francia 86
PL - Polonia 80
GB - Regno Unito 67
FI - Finlandia 57
KR - Corea 55
RU - Federazione Russa 32
BE - Belgio 13
EU - Europa 6
JP - Giappone 6
KG - Kirghizistan 6
ES - Italia 5
HU - Ungheria 5
SG - Singapore 5
AU - Australia 4
BR - Brasile 4
CA - Canada 4
IR - Iran 4
CL - Cile 3
GR - Grecia 3
HK - Hong Kong 3
IL - Israele 3
RO - Romania 3
A2 - ???statistics.table.value.countryCode.A2??? 2
NL - Olanda 2
SC - Seychelles 2
DK - Danimarca 1
DM - Dominica 1
ID - Indonesia 1
IN - India 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
NZ - Nuova Zelanda 1
PH - Filippine 1
RS - Serbia 1
Totale 20.926
Città #
Woodbridge 5.872
Wilmington 5.457
Houston 4.718
Fairfield 673
Ann Arbor 481
Chandler 370
Seattle 271
Ashburn 257
Jacksonville 245
Cambridge 223
Dublin 179
Medford 145
Dearborn 121
Kraków 78
Lawrence 66
Beijing 64
Mülheim 39
New York 39
San Diego 30
Menlo Park 28
Rome 28
San Mateo 16
Boardman 15
Brussels 13
Milan 13
Verona 11
London 10
Zhengzhou 10
Redwood City 9
Hefei 7
Nanjing 7
Saint Petersburg 7
Chicago 6
Detroit 6
Falls Church 6
Kunming 6
Palo Alto 6
Berlin 5
Cagliari 5
Helsinki 5
Shanghai 5
University Park 5
Auburn Hills 4
Justice 4
Los Angeles 4
Miskolc 4
Mountain View 4
Norwalk 4
Nürnberg 4
Redmond 4
Seoul 4
Siena 4
Catania 3
Indiana 3
San Francisco 3
São Paulo 3
Toronto 3
Ypsilanti 3
Agliana 2
Garden City 2
Guangzhou 2
Hangzhou 2
Hong Kong 2
Hounslow 2
Jinan 2
Napoli 2
Ningbo 2
Pianella 2
Sant'Angelo del Pesco 2
Singapore 2
Suceava 2
Venafro 2
Wenzhou 2
Adelaide 1
Amsterdam 1
Athens 1
Auckland 1
Augusta 1
Baulkham Hills 1
Budapest 1
Caserta 1
Central 1
Changchun 1
Changsha 1
Chaoyang 1
Chatsworth 1
Chisinau 1
Chiswick 1
Chongqing 1
Claix 1
Clearwater 1
Courbevoie 1
Culver City 1
Fremont 1
Fuzhou 1
Great Falls 1
Groningen 1
Guiyang 1
Idice 1
Kemerovo 1
Totale 19.672
Nome #
A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase 466
Radiochromatographic assay of N-acyl-phosphatidylethanolamine-specific phospholipase D activity 435
Endocannabinoids in adipocytes during differentiation and their role in glucose uptake 431
Molecular Identification of Albumin and Hsp70 as Cytosolic Anandamide-Binding Proteins 429
The anandamide membrane transporter and the therapeutic implications of its inhibition 422
Characterization of the endocannabinoid system in boar spermatozoa and implications for sperm capacitation and acrosome reaction 417
High endogenous cannabinoid levels in the cerebrospinal fluid of untreated Parkinson's disease patients 417
The endocannabinoid system is dysregulated in multiple sclerosis and in experimental autoimmune encephalomyelitis. 416
Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis. 413
Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases. 412
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor. 411
Mouse blastocyts release a lipid which activates anandamide hydrolase in intact uterus 406
Endocannabinoids, related compounds and their metabolic routes 406
Human adipose tissue binds and metabolizes the endocannabinoids anandamide and 2-arachidonoylglycerol 405
The brain cytoplasmic RNA BC1 regulates dopamine D2 receptor-mediated transmission in the striatum 399
New insights into endocannabinoid degradation and its therapeutic potential 398
Methods to assay anandamide hydrolysis and transport in synaptosomes. 398
Effects of palmitoylation of Cys(415) in helix 8 of the CB(1) cannabinoid receptor on membrane localization and signalling 396
Evidence for the intracellular accumulation of anandamide in adiposomes 395
null 393
N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors 392
Levels of N-Acylethanolamines in Human Tumors: In Search of Reliable Data 387
Fatty acid amide hydrolase: a gate-keeper of the endocannabinoid system 387
Methylation and acetylation of 15-hydroxyanandamide modulate its interaction with the endocannabinoid system. 386
Endocannabinoid biochemistry: What do we know after 50 years? 386
Endocannabinoids and their involvement in the neurovascular system. 385
Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties. 384
Enol carbamates as inhibitors of fatty acid amide hydrolase (FAAH) endowed with high selectivity for FAAH over the other targets of the endocannabinoid system. 383
5-Lipoxygenase and anandamide hydrolase (FAAH) mediate the antitumor activity of cannabidiol, a non-psychoactive cannabinoid 382
Activation of type-2 cannabinoid receptor inhibits neuroprotective and antiinflammatory actions of glucocorticoid receptor α: when one is better than two. 380
Modulation of the endocannabinoid system by focal brain ischemia in the rat is involved in neuroprotection afforded by 17 beta-estradiol 378
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 377
Endocannabinoids stimulate human melanogenesis via type-1 cannabinoid receptor. 377
Characterization of biotin-anandamide, a novel tool for the visualization of anandamide accumulation 376
Expression of the endocannabinoid system in the bi-potential HEL cell line: commitment to the megakaryoblastic lineage by 2-arachidonoylglycerol 375
Distinct modulation of the endocannabinoid system upon kainic acid-induced in vivo seizures and in vitro epileptiform bursting. 375
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice 375
Differential regulation of fatty acid amide hydrolase promoter in human immune cells and neuronal cells by leptin and progesterone 372
Lipopolysaccharide downregulates fatty acid amide hydrolase expression and increases anandamide levels in human peripheral lymphocytes 368
Changes in endocannabinoid contents in reward-related brain regions of alcohol-exposed rats, and their possible relevance to alcohol relapse. 366
The endocannabinoid system in neurodegeneration. 365
Lipid rafts control signaling of type-1 cannabinoid receptors in neuronal cells: Implications for anandamide-induced apoptosis 363
Pitfalls and solutions in assaying anandamide transport in cells. 361
Mouse blastocysts release a lipid which activates anandamide hydrolase in intact uterus 355
Further insights into the regulation of human FAAH by progesterone and leptin implications for endogenous levels of anandamide and apoptosis of immune and neuronal cells. 355
Anandamide inhibits metabolism and physiological actions of 2-arachidonoylglycerol in the striatum 346
Design and synthesis of biotinylated probes for n-acyl-ethanolamines 340
Rat and human fatty acid amide hydrolases: overt similarities and hidden differences. 329
Prostaglandin ethanolamides (prostamides): in vitro pharmacology and metabolism 328
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor 321
Effect of lipid rafts on Cb2 receptor signaling and 2-arachidonoyl-glycerol metabolism in human immune cells 317
Regulation of endocannabinoid system by lipid rafts along the neuroimmune axis 184
Activity-based protein profiling reveals off-target proteins of the FAAH inhibitor BIA 10-2474 150
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity 124
Development of novel multipotent compounds modulating endocannabinoid and dopaminergic systems 108
Advances in the discovery of fatty acid amide hydrolase inhibitors: what does the future hold? 105
Characterization of Endocannabinoid System and Interleukin Profiles in Ovine AEC: Cannabinoid Receptors Type-1 and Type-2 as Key Effectors of Pro-Inflammatory Response 102
The endocannabinoid hydrolase FAAH is an allosteric enzyme 98
Assay of NAPE-PLD Activity 96
The novel, orally available and peripherally restricted selective cannabinoid CB2 receptor agonist LEI-101 prevents cisplatin-induced nephrotoxicity 91
Lipid Discovery by Combinatorial Screening and Untargeted LC-MS/MS 76
Palmitoylation of cysteine 415 of CB1 receptor affects ligand-stimulated internalization and selective interaction with membrane cholesterol and caveolin 1 75
Plant-Derived and Endogenous Cannabinoids in Epilepsy 72
Bisphenol a deranges the endocannabinoid system of primary sertoli cells with an impact on inhibin b production 36
Dynamic changes of anandamide in the cerebrospinal fluid of Parkinson's disease patients 20
Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents 13
In silico and in vitro analysis of major cannabis-derived compounds as fatty acid amide hydrolase inhibitors 12
Endocannabinoids and platelets - Differentiation 9
Chemical Proteomics Reveals Off-Targets of the Anandamide Reuptake Inhibitor WOBE437 8
Endocannabinoids and platelets - Signalling pathways 8
Totale 21.023
Categoria #
all - tutte 36.433
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.433


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20191.677 0 0 0 0 0 0 0 0 0 464 614 599
2019/20205.662 434 403 383 543 472 585 493 506 534 424 447 438
2020/20213.658 419 480 394 455 420 434 395 346 63 81 129 42
2021/2022665 22 80 37 22 18 44 36 19 52 74 45 216
2022/2023930 108 82 45 123 70 203 61 59 83 4 68 24
2023/2024174 37 11 11 17 18 55 6 9 10 0 0 0
Totale 21.023